Hyperacute rejection is due to:
The core concept here is the immune response mechanism. The key is the presence of preformed antibodies that immediately bind to the donor organ, triggering a cascade leading to complement activation and coagulation. This leads to thrombosis in the graft's blood vessels, causing the organ to fail rapidly. The main antibodies involved are IgM, which are the first to respond.
Now, the correct answer should be related to preformed antibodies. The options might include other types of immune responses like cell-mediated (acute rejection) or delayed hypersensitivity (chronic rejection). Let's think about the options. For example, if an option says "cell-mediated immunity," that's incorrect because hyperacute is antibody-mediated. Another option might mention T-cells, which are involved in acute rejection. Also, maybe an option about ABO incompatibility is there, which is a type of hyperacute rejection.
For the wrong options: Option A could be about cell-mediated, which is acute. Option B might be about T-cells again. Option C could be about delayed hypersensitivity, which is chronic. Option D might be about sensitization, which is part of acute. Each of these is incorrect because they don't fit the rapid onset caused by preformed antibodies.
Clinical pearl: Remember that hyperacute rejection is prevented by crossmatching before transplantation to detect these preformed antibodies. If a crossmatch is positive, the transplant is contraindicated.
So, the correct answer is preformed antibodies. Need to structure the explanation with all the required sections, making sure each part is concise and meets the character limit. Check that each section is properly labeled and the explanations are accurate without being too verbose.
**Core Concept**
Hyperacute rejection is an immediate immune response in organ transplantation caused by preformed **IgM/IgG antibodies** in the recipient reacting with donor antigens, typically **ABO blood group antigens** or **HLA antibodies**. This triggers **complement activation**, endothelial damage, and **thrombotic microangiopathy**, leading to graft failure within minutes to hours.
**Why the Correct Answer is Right**
Hyperacute rejection occurs when the recipient has **pre-existing antibodies** (often from prior transfusions, pregnancies, or transplants) against donor antigens. These antibodies bind to endothelial cells, activating the **classical complement pathway**, which causes **C3a/C5a release**, neutrophil recruitment, and **platelet aggregation**. This results in **thrombosis, hemorrhage, and infarction** of the graft. The absence of T-cell involvement distinguishes it from acute/chronic rejection.
**Why Each Wrong Option is Incorrect**
**Option A:** *Cell-mediated immunity via CD4+ T-cells* is characteristic of **acute rejection**, not hyperacute.
**Option B:** *Delayed hypersensitivity (Type IV)* involves **CD8+ T-cells** and occurs over days to weeks